2012 Economic Outlook -- Report Highlights Alexion Pharmaceuticals, Inc. and Cree, Inc.
February 13 2012 - 9:00AM
Marketwired
Today, www.BrightonMarkets.com announced new reports highlighting
Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) and Cree, Inc.
(NASDAQ: CREE). Gain market insight with full analysis and research
downloads available at
www.BrightonMarkets.com/index.php?coa=ALXN&cob=CREE.
Economic fundamentals leading into 2012 have set a generally
positive pace with GDP growth likely to pick up through the coming
year. However, there are several important caveats to note as the
world economy continues to face headwinds and risks weigh to the
downside. Positive outlooks are conditional on fiscal policy in
payroll taxes and unemployment insurance benefits and upon the
easing of the European debt situation. A repeat of volatility
experience in 2011 is likely in 2012, as perceptions about the
strength of the U.S. economy and the euro zone will vary over time
as events unfold.
Despite the current situation, our team continues to identify
high momentum situations with growth potential -- there remains
strong opportunity within careful discretion.
Brighton Markets is releasing new coverage on Alexion
Pharmaceuticals, Inc. for its current position within the
healthcare industry. Alexion Pharmaceuticals, Inc. (Alexion) is a
biopharmaceutical company engaged in the discovery, development and
commercialization of therapeutic products aimed at treating
patients with severe and life-threatening disease states, including
those in the therapeutic areas of hematology, nephrology (including
transplant rejection), neurology, ophthalmology and cancer. The
full research report on Alexion Pharmaceuticals, Inc. (NASDAQ:
ALXN) is available here:
www.BrightonMarkets.com/index.php?coa=ALXN.
Brighton Markets has released research on Cree, Inc. for its
changing role within the technology industry. Cree, Inc. (Cree)
develops and manufactures semiconductor materials and devices
primarily based on silicon carbide (SiC), gallium nitride (GaN) and
related compounds. It focuses its expertise in SiC and GaN on light
emitting diode (LED) products. It also develops power and radio
frequency (RF) products. The full research report on Cree, Inc.
(NASDAQ: CREE) is available here:
www.BrightonMarkets.com/index.php?cob=CREE.
About Brighton Markets Brighton Markets was founded on the
guiding principle of providing highly relevant, meaningful, and
actionable information direct to investors. Across the investment
spectrum, Brighton Markets shines light on today's events.
Contact: Jean Barnes Email: Email Contact
www.BrightonMarkets.com
Alexion Pharmaceuticals (NASDAQ:ALXN)
Historical Stock Chart
From May 2024 to Jun 2024
Alexion Pharmaceuticals (NASDAQ:ALXN)
Historical Stock Chart
From Jun 2023 to Jun 2024